Physician profile
Robert D Floyd
NPI 1275514028
$3,375.03
in general payments reported to CMS, 2019-2025
37 companies · $514 in 2025
The $514 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $266 · 2021: $499 · 2022: $635 · 2023: $553 · 2024: $628 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,695.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $325.52 | 2019-2025 | Jardiance |
| Amgen INC. | $227.45 | 2019-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $226.61 | 2020-2025 | |
| Abbvie INC. | $225.08 | 2021-2025 | |
| Novo Nordisk INC | $211.28 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $188.39 | 2020-2025 | Breztri, Airsupra |
| Lilly USA, LLC | $153.23 | 2022-2025 | Mounjaro, Jardiance |
| Merck Sharp & Dohme LLC | $150.31 | 2019-2025 | Verquvo, Vaxneuvance, Gardasil 9 |
| Mylan Specialty L.P. | $149.36 | 2019-2024 | Yupelri, Yupelri |
| Janssen Pharmaceuticals, INC | $134.63 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $129.65 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $128.50 | 2021-2025 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $124.53 | 2019-2025 | Shingrix |
| Abbott Laboratories | $119.23 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Insulet Corporation | $96.72 | 2022-2025 | Omnipod |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.